AMARIN CORP PLC\UK Additional Paid in Capital, Common Stock
AMARIN CORP PLC\UK (AMRN) had Additional Paid in Capital, Common Stock of $977.87 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2018-02-27
- 2017-12-31: Additional Paid in Capital, Common Stock $977.87M.
- 2017-09-30: Additional Paid in Capital, Common Stock $974.34M.
- 2017-06-30: Additional Paid in Capital, Common Stock $970.80M.
- 2017-03-31: Additional Paid in Capital, Common Stock $967.07M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2017-12-31 | $977.87M 10-K · filed 2018-02-27 |
| 2017-09-30 | $974.34M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $970.80M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $967.07M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $964.91M 10-K · filed 2018-02-27 |
| 2016-09-30 | $961.69M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $822.01M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $818.59M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $816.17M 10-K · filed 2017-03-01 |
| 2015-09-30 | $812.41M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $802.85M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $769.53M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $738.89M 10-K · filed 2016-02-25 |
| 2014-09-30 | $738.44M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $733.11M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $740.82M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $738.75M 10-K · filed 2015-03-03 |
| 2013-09-30 | $739.52M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $630.57M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $625.09M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $619.27M 10-K · filed 2014-02-27 |
| 2012-09-30 | $613.09M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $593.34M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $478.76M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $449.39M 10-K · filed 2013-02-28 |
| 2011-09-30 | $443.40M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $417.41M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $206.72M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |